Skip to content
Recall Observatory FDA recall evidence

Drug product

TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02

D-0656-2024

August 22, 2024

Class II

Product summary

Firm
ProRx LLC
Event
Event 95190
Status
Ongoing
Classification
Class II
Quantity
1,732 vials
Official record key
drug-enforcement:D-0656-2024

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot# ProRx052224, BUD 11/21/2024 ProRx061024, BUD 12/09/2024

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility